Elite in Pulmonary Hypertension

Dr. Elizabeth Klings

Intensive Care Medicine
Office
725 Albany St Ste B, 
Boston, MA 

Elite in Pulmonary Hypertension
Office
725 Albany St Ste B, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Elizabeth Klings is an Intensive Care Medicine provider in Boston, Massachusetts. Dr. Klings is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. Her top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Heart Failure with Preserved Ejection Fraction (HFpEF), Venous Thromboembolism (VTE), and Thrombectomy.

Her clinical research consists of co-authoring 77 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 35 articles and participated in 5 clinical trials in the study of Pulmonary Hypertension.

Specialties
Intensive Care Medicine
Licenses
Internal Medicine in MA
Hospital Affiliations
Boston Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Office
725 Albany St Ste B, Boston, MA 02118
Call: 617-638-7480
Other Locations
Boston Medical Center
1 Boston Medical Ctr Pl, Boston, MA 02118
Call: 617-638-7480

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: February 06, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
A Phase III, Multicenter, Randomized, Double-blind Study to Assess Efficacy and Safety of Two Doses of Crizanlizumab Versus Placebo, With or Without Hydroxyurea/ Hydroxycarbamide Therapy, in Adolescent and Adult Sickle Cell Disease Patients With Vaso-Occlusive Crises (STAND)
A Phase III, Multicenter, Randomized, Double-blind Study to Assess Efficacy and Safety of Two Doses of Crizanlizumab Versus Placebo, With or Without Hydroxyurea/ Hydroxycarbamide Therapy, in Adolescent and Adult Sickle Cell Disease Patients With Vaso-Occlusive Crises (STAND)
Enrollment Status: Active_not_recruiting
Publish Date: January 30, 2026
Intervention Type: Drug
Study Drug: Crizanlizumab
Study Phase: Phase 3
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Completed
Publish Date: June 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)
Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)
Enrollment Status: Active_not_recruiting
Publish Date: April 29, 2025
Intervention Type: Biological, Other
Study Drug: Red Blood Cell
Study Phase: Phase 3
A Phase II Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients With Sickle Cell Diseases
A Phase II Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients With Sickle Cell Diseases
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drug: Riociguat
Study Phase: Phase 2
The Safety and Efficacy of Macitentan for Treatment of Pulmonary Hypertension in Sickle Cell Disease
The Safety and Efficacy of Macitentan for Treatment of Pulmonary Hypertension in Sickle Cell Disease
Enrollment Status: Terminated
Publish Date: December 08, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

77 Total Publications

Let's Not Keep Acute Chest Syndrome Under an Umbrella.
Let's Not Keep Acute Chest Syndrome Under an Umbrella.
Journal: American journal of respiratory and critical care medicine
Published: December 11, 2025
View All 77 Publications
Similar Doctors
Aaron B. Waxman
Elite in Pulmonary Hypertension
Dr. Aaron B. Waxman
Cardiology | Intensive Care Medicine
Elite in Pulmonary Hypertension
Dr. Aaron B. Waxman
Cardiology | Intensive Care Medicine

Brigham And Women's Hospital, Heart And Vascular Center

70 Francis Street, Carl J. And Ruth Shapiro Cardiovascular Center, 
Boston, MA 
 (1.8 miles away)
617-525-9733
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dr. Aaron B. Waxman is the director of the Pulmonary Vascular Disease Program at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School.After receiving his medical degree from Yale University School of Medicine, Dr. Waxman completed a residency in internal medicine at Yale New Haven Hospital. He then completed two fellowships: the first at Howard Hughes Medical Institute, and the second in pulmonary and critical care at Yale New Haven Hospital. He is board certified in critical care medicine, internal medicine and pulmonary disease.Dr. Waxman’s clinical interests include pulmonary arterial hypertension (PAH), right heart failure, thromboembolic disease and pulmonary vascular disease. His research focuses on the inflammatory mechanisms of pulmonary vascular remodeling that lead to right heart failure. His research into the regulation of cell death proteins by IL-6 cytokines in mice led to the discovery of a relationship between dyspnea and mitochondrial dysfunction, and resulted in additional clinical studies examining the abnormalities of inflammatory mediators and oxygen extraction in patients with PAH. He has authored over 110 peer-reviewed publications and has received funding from the National Institutes of Health and the National Heart, Lung, and Blood Institute. Dr. Waxman is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Interstitial Lung Disease, Lung Transplant, and Thrombectomy.

Ioana Preston
Elite in Pulmonary Hypertension
Dr. Ioana Preston
Intensive Care Medicine
Elite in Pulmonary Hypertension
Dr. Ioana Preston
Intensive Care Medicine

Tufts Medical Center

800 Washington St, 
Boston, MA 
 (1.2 miles away)
617-636-6377
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ioana Preston is an Intensive Care Medicine provider in Boston, Massachusetts. Dr. Preston is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Hypertension. Her top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Heart Failure with Preserved Ejection Fraction (HFpEF), Cerebral Hypoxia, and Lung Transplant.

James Klinger
Elite in Pulmonary Hypertension
Dr. James Klinger
Intensive Care Medicine
Elite in Pulmonary Hypertension
Dr. James Klinger
Intensive Care Medicine

Rhode Island Hospital

593 Eddy St, 
Providence, RI 
 (40.1 miles away)
401-444-4000
Languages Spoken:
English
See accepted insurances

James Klinger is an Intensive Care Medicine provider in Providence, Rhode Island. Dr. Klinger is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Cerebral Hypoxia, and Chronic Obstructive Pulmonary Disease (COPD).

VIEW MORE PULMONARY HYPERTENSION DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Klings's expertise for a condition
ConditionClose
  • Elite
  • Pulmonary Hypertension
    Dr. Klings is
    Elite
    . Learn about Pulmonary Hypertension.
    See more Pulmonary Hypertension experts
  • Distinguished
  • Pulmonary Veno-Occlusive Disease
    Dr. Klings is
    Distinguished
    . Learn about Pulmonary Veno-Occlusive Disease.
    See more Pulmonary Veno-Occlusive Disease experts
  • Advanced
  • Cerebral Hypoxia
    Dr. Klings is
    Advanced
    . Learn about Cerebral Hypoxia.
    See more Cerebral Hypoxia experts
  • Chronic Obstructive Pulmonary Disease (COPD)
    Dr. Klings is
    Advanced
    . Learn about Chronic Obstructive Pulmonary Disease (COPD).
    See more Chronic Obstructive Pulmonary Disease (COPD) experts
  • Emphysema
    Dr. Klings is
    Advanced
    . Learn about Emphysema.
    See more Emphysema experts
  • Heart Failure with Preserved Ejection Fraction (HFpEF)
    Dr. Klings is
    Advanced
    . Learn about Heart Failure with Preserved Ejection Fraction (HFpEF).
    See more Heart Failure with Preserved Ejection Fraction (HFpEF) experts
  • Sarcoidosis
    Dr. Klings is
    Advanced
    . Learn about Sarcoidosis.
    See more Sarcoidosis experts
  • Systemic Sclerosis (SSc)
    Dr. Klings is
    Advanced
    . Learn about Systemic Sclerosis (SSc).
    See more Systemic Sclerosis (SSc) experts
View All 7 Advanced Conditions
  • Experienced
  • Acute Interstitial Pneumonia
    Dr. Klings is
    Experienced
    . Learn about Acute Interstitial Pneumonia.
    See more Acute Interstitial Pneumonia experts
  • Asthma
    Dr. Klings is
    Experienced
    . Learn about Asthma.
    See more Asthma experts
  • Bullae
    Dr. Klings is
    Experienced
    . Learn about Bullae.
    See more Bullae experts
  • Chronic Cough
    Dr. Klings is
    Experienced
    . Learn about Chronic Cough.
    See more Chronic Cough experts
  • Chronic Eosinophilic Pneumonia
    Dr. Klings is
    Experienced
    . Learn about Chronic Eosinophilic Pneumonia.
    See more Chronic Eosinophilic Pneumonia experts
  • COVID-19
    Dr. Klings is
    Experienced
    . Learn about COVID-19.
    See more COVID-19 experts
View All 18 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.